中华关节外科杂志(电子版)
中華關節外科雜誌(電子版)
중화관절외과잡지(전자판)
CHINESE JOURNAL OF JOINT SURGERY(ELECTRONIC VERSION)
2014年
3期
346-350
,共5页
孙长鲛%柴伟%潘勇卫%周勇刚
孫長鮫%柴偉%潘勇衛%週勇剛
손장교%시위%반용위%주용강
感染%利奈唑胺%骨水泥%占位器%力学性能
感染%利奈唑胺%骨水泥%佔位器%力學性能
감염%리내서알%골수니%점위기%역학성능
Infection%linezolid%Bone cement%Spacer%Mechanical properties
目的:探讨利奈唑胺骨水泥物理和力学性能改变,以指导利奈唑胺骨水泥在治疗人工关节置换术后感染中的临床应用。方法根据在40 g骨水泥中加入不同剂量的利奈唑胺,将样本共分成8个组,每组测定5个样本,8组分别是:Ⅰ组为对照组,不加抗生素,第Ⅱ到第Ⅷ组加入抗生素的量分别为1.2、2.4、3.6、4.8、6.0、7.2及8.4g。分别测定各组面团期时间、压缩强度、弯曲模量和弯曲强度。结果各组面团时间在2′50″~3′40″之间。随着抗生素剂量的增加,面团时间也随之增加。各组的压缩强度、弯曲模量和弯曲强度均优于ISO 5833标准,且有统计学差异( P<0.05),Ⅱ组的压缩强度、弯曲模量和弯曲强度与对照组没有统计学差异,但高于其他各组,与其他各组间有统计学差异。而第Ⅷ组的压缩强度、弯曲模量和弯曲强度均低于其他各组,且有统计学差异。结论面团时间随着利奈唑胺剂量的增加而增加。如果利奈唑胺骨水泥用于预防性使用,则每40 g骨水泥中最多可以加入1.2g利奈唑胺,否则会影响骨水泥的强度。如果利奈唑胺骨水泥用于制作占位器,在每40 g骨水泥中最多不要加入超过7.2 g的利奈唑胺,不至于太影响骨水泥占位器的强度,但是加入的最佳剂量是多少,本系列实验的另一部分会有详细交代。
目的:探討利奈唑胺骨水泥物理和力學性能改變,以指導利奈唑胺骨水泥在治療人工關節置換術後感染中的臨床應用。方法根據在40 g骨水泥中加入不同劑量的利奈唑胺,將樣本共分成8箇組,每組測定5箇樣本,8組分彆是:Ⅰ組為對照組,不加抗生素,第Ⅱ到第Ⅷ組加入抗生素的量分彆為1.2、2.4、3.6、4.8、6.0、7.2及8.4g。分彆測定各組麵糰期時間、壓縮彊度、彎麯模量和彎麯彊度。結果各組麵糰時間在2′50″~3′40″之間。隨著抗生素劑量的增加,麵糰時間也隨之增加。各組的壓縮彊度、彎麯模量和彎麯彊度均優于ISO 5833標準,且有統計學差異( P<0.05),Ⅱ組的壓縮彊度、彎麯模量和彎麯彊度與對照組沒有統計學差異,但高于其他各組,與其他各組間有統計學差異。而第Ⅷ組的壓縮彊度、彎麯模量和彎麯彊度均低于其他各組,且有統計學差異。結論麵糰時間隨著利奈唑胺劑量的增加而增加。如果利奈唑胺骨水泥用于預防性使用,則每40 g骨水泥中最多可以加入1.2g利奈唑胺,否則會影響骨水泥的彊度。如果利奈唑胺骨水泥用于製作佔位器,在每40 g骨水泥中最多不要加入超過7.2 g的利奈唑胺,不至于太影響骨水泥佔位器的彊度,但是加入的最佳劑量是多少,本繫列實驗的另一部分會有詳細交代。
목적:탐토리내서알골수니물리화역학성능개변,이지도리내서알골수니재치료인공관절치환술후감염중적림상응용。방법근거재40 g골수니중가입불동제량적리내서알,장양본공분성8개조,매조측정5개양본,8조분별시:Ⅰ조위대조조,불가항생소,제Ⅱ도제Ⅷ조가입항생소적량분별위1.2、2.4、3.6、4.8、6.0、7.2급8.4g。분별측정각조면단기시간、압축강도、만곡모량화만곡강도。결과각조면단시간재2′50″~3′40″지간。수착항생소제량적증가,면단시간야수지증가。각조적압축강도、만곡모량화만곡강도균우우ISO 5833표준,차유통계학차이( P<0.05),Ⅱ조적압축강도、만곡모량화만곡강도여대조조몰유통계학차이,단고우기타각조,여기타각조간유통계학차이。이제Ⅷ조적압축강도、만곡모량화만곡강도균저우기타각조,차유통계학차이。결론면단시간수착리내서알제량적증가이증가。여과리내서알골수니용우예방성사용,칙매40 g골수니중최다가이가입1.2g리내서알,부칙회영향골수니적강도。여과리내서알골수니용우제작점위기,재매40 g골수니중최다불요가입초과7.2 g적리내서알,불지우태영향골수니점위기적강도,단시가입적최가제량시다소,본계렬실험적령일부분회유상세교대。
Objective To study the physical and mechanical properties of the linezolid-loaded bone cement in order to guide the clinical application of the linezolid-loaded bone cement in the treatment of the infection after total joint arthroplasty .Methods The specimens of the bone cement ( each of 40 g) were divided into eight groups based on the different dosage of linezolid in them ( five specimens in each group ) . Group Ⅰwith no linezolid served as the control group;group Ⅱwith 1.2 g, group Ⅲwith 2.4 g group Ⅳwith 3.6 g, group Ⅴwith 4.8 g,group Ⅵwith 6.0 g, group Ⅶ with 7.2 g,and group Ⅷwith 8.4 g.The dough time , compressive strength , bending strength and bending elastic modulus were measured .Results The dough time of all the groups was between 2′50″and 3′40″.The dough time increased with the dose of linezolid .compressive strength , bending strength and bending elastic modulus were higher than those of the ISO 5833 standard, and there was significant difference between the linezolid-loaded bone cement and the ISO 5833 standard.There was no significant difference between group Ⅱ and the control group, but the mechanical properties of group Ⅱ was higher than those of the other groups , and there were significant differences between group Ⅱand other groups .The mechanical properties of group Ⅷwas lower than those of the other groups , and there were significant differences between group Ⅷ and other groups . Conclusions The dough time increased with the dose of linezolid .If the linezolid-loaded bone cement is used to prevent infection , the maximum dose of linezolid in 40 g bone cement should be 1.2 g, otherwise it would decrease the strength of the bone cement .If the linezolid-loaded bone cement is used to make spacer , the maximum dose of linezolid in 40 g bone cement should be 7.2 g, which would not significantly affect the strength of bone cement spacer , and the optimal dose to make bone cement spacer will be discussed in another relevant experiment .